Basel, Switzerland

Lonza Capsugel

Global leader in empty hard capsules (Capsugel brand) and ingredient delivery technologies for pharmaceutical and nutraceutical manufacturers.

Lonza Capsugel is a division of Lonza Group with over 100 years of experience in capsule design and manufacturing. The company produces a comprehensive portfolio of hard empty capsules for pharmaceutical and nutraceutical applications, including gelatin (Coni-Snap®), HPMC (Vcaps®), pullulan (Plantcaps®), and specialized formats for enteric, inhalation and vaginal delivery. The company manufactures capsules at facilities in North America, Europe, India, China and Japan, and operates ingredients production facilities in North America and China.

In addition to empty capsules, Lonza Capsugel offers contract development and manufacturing (CDMO) services through its pharmaceutical division in Tampa, Florida, and nutraceutical division with advanced technologies including Licaps® liquid-filled capsules, beadlet technology, multi-particulate systems, and tablet-in-capsule formats. The company holds approximately 120 patent families covering capsule designs and health ingredients. It produces proprietary health ingredients including UC-II® collagen, Carnipure® L-carnitine, ChromeMate® chromium, ResistAid® arabinogalactan, and L-OptiZinc® zinc, marketed primarily for joint health, exercise recovery, and immune support applications.

The company maintains 20 global locations providing supply chain, regulatory, quality and technical support. It has committed to achieving net-zero greenhouse gas emissions by 2050, with plans to reduce absolute scope 1 and 2 GHG emissions by more than 40% by 2030. The ACHIEV® digital platform provides customers with self-service tools for ordering, regulatory support, and technical documentation.

Capabilities

Supplements
Capsules
Encapsulation
Microencapsulation

Tags

Also in Switzerland

Dry — Capsule filling

See all in Switzerland →

Similar manufacturers

Also working in Dry — Capsule filling